Market Place
Sourcing Support
All News #Library
Biotech
Flare Therapeutics To Present Three Posters At AACR 2026 Meeting
06 Apr 2026 //
GLOBENEWSWIRE
Flare Therapeutics Unveils FX-909 Phase 1A Data At 2026 ASCO
27 Feb 2026 //
GLOBENEWSWIRE
Flare Therapeutics Joins Piper Sandler Healthcare Conference
25 Nov 2025 //
GLOBENEWSWIRE
Flare Therapeutics Presents FX-909 Ph1A Biomarker Analysis
07 Nov 2025 //
GLOBENEWSWIRE
Flare Therapeutics Joins November Investor Conferences
03 Nov 2025 //
GLOBENEWSWIRE
Flare Therapeutics To Present FX-909 Phase 1a Biomarker Analysis
30 Oct 2025 //
GLOBENEWSWIRE
Flare Therapeutics Unveils FX-909 Phase 1 Study Data
24 Oct 2025 //
GLOBENEWSWIRE
Flare Therapeutics To Present FX-909 Phase 1a Data
14 Oct 2025 //
GLOBENEWSWIRE
Flare Therapeutics to Present at September Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Flare Therapeutics Starts Phase 1B Study of FX-909
05 Aug 2025 //
GLOBENEWSWIRE
Flare Therapeutics at Jefferies Global Healthcare Conference
28 May 2025 //
GLOBENEWSWIRE
Flare Therapeutics Enters Discovery Collaboration with Roche
14 Nov 2024 //
BUSINESSWIRE
Flare Therapeutics Partners with Roche to Target Transcription Factors
12 Nov 2024 //
PR NEWSWIRE
Flare to Present Data in Support of Candidate FX-909`s Phase 1 Development
31 Oct 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.